Patients With HR-Positive Breast Cancer Can Safely Use ART Patients With HR-Positive Breast Cancer Can Safely Use ART
New data from the POSITIVE trial show the efficacy and short-term safety of fertility preservation and assisted reproductive technology (ART) for young women with HR-positive breast cancer.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - December 8, 2023 Category: Cancer & Oncology Tags: Hematology-Oncology Source Type: news
Genes That Boost Fertility Also Shorten Our Life, Study Suggests
A study of DNA from half a million volunteers supports an old evolutionary theory about why our bodies eventually wear out. (Source: NYT Health)
Source: NYT Health - December 8, 2023 Category: Consumer Health News Authors: Carl Zimmer Tags: your-feed-science Research Genetics and Heredity Longevity Evolution (Biology) Reproduction (Biological) Science Advances (Journal) Source Type: news
Roche ’s inavolisib combination reduces the risk of disease progression by 57% in people with advanced hormone receptor-positive, HER2-negative breast cancer with a PIK3CA mutation
Inavolisib in combination with palbociclib and fulvestrant more than doubled progression-free survival compared to palbociclib and fulvestrant alone1The inavolisib combination has the potential to address resistance to treatment and poor prognosis associated with PIK3CA mutations2-5These new data are being presented today in an oral presentation at the 2023 San Antonio Breast Cancer Symposium and shared with health authoritiesBasel, 8 December 2023 - Roche (SIX: RO, ROG; OTCQX: RHHBY) presented today positive results from the Phase III INAVO120 study evaluating inavolisib in combination with palbociclib (Ibrance ®) and fu...
Source: Roche Investor Update - December 8, 2023 Category: Pharmaceuticals Source Type: news
Roche ’s inavolisib combination reduces the risk of disease progression by 57% in people with advanced hormone receptor-positive, HER2-negative breast cancer with a PIK3CA mutation
Inavolisib in combination with palbociclib and fulvestrant more than doubled progression-free survival compared to palbociclib and fulvestrant alone1The inavolisib combination has the potential to address resistance to treatment and poor prognosis associated with PIK3CA mutations2-5These new data are being presented today in an oral presentation at the 2023 San Antonio Breast Cancer Symposium and shared with health authoritiesBasel, 8 December 2023 - Roche (SIX: RO, ROG; OTCQX: RHHBY) presented today positive results from the Phase III INAVO120 study evaluating inavolisib in combination with palbociclib (Ibrance ®) and fu...
Source: Roche Media News - December 8, 2023 Category: Pharmaceuticals Source Type: news
Study 'Underscores' Value of Early Fertility Counseling for Breast Cancer Patients
(MedPage Today) -- SAN ANTONIO -- Using fertility preservation and/or assisted reproductive technologies (ART) did not adversely impact 3-year cancer recurrence rates among patients with hormone receptor (HR)-positive breast cancer who paused... (Source: MedPage Today OB/GYN)
Source: MedPage Today OB/GYN - December 8, 2023 Category: OBGYN Source Type: news
SABCS: Positive Outcomes Seen When Pausing Endocrine Therapy to Become Pregnant
THURSDAY, Dec. 7, 2023 -- Among patients with hormone receptor-positive breast cancer who paused endocrine therapy (ET) to become pregnant, fertility preservation and/or assisted reproductive technologies (ART) do not adversely affect three-year... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - December 7, 2023 Category: Pharmaceuticals Source Type: news
Fertility doctor accused of using his sperm to inseminate patient
A former physician in Washington state has voluntarily surrendered his license after one of his previous fertility patients in California accused him of using his sperm to inseminate her, claiming she has DNA evidence that he fathered one of her children, according to a state report. The…#christopherherndon #patienta #herndon #susangregg #chrisherndon #uwmedicine (Source: Reuters: Health)
Source: Reuters: Health - December 7, 2023 Category: Consumer Health News Source Type: news
Call to help UK IVF patients donate unused embryos after shortage hinders research
Scientists complain after ‘sheer waste’ of human embryos discarded despite patients’ wishesLeading scientists are calling for a change in the law to help IVF patients donate unused embryos to biomedical research after a collapse in donations over the past 15 years.The increasing commercialisation of IVF, overstretched NHS clinics and cumbersome paperwork are blamed for a 25-fold decrease in the number of donated embryos. Scientists described some patients going to “extraordinary lengths” to ensure their embryos could be used for research rather than discarded, with many private clinics failing to routinely offer ...
Source: Guardian Unlimited Science - December 6, 2023 Category: Science Authors: Hannah Devlin Science correspondent Tags: Embryos Biology Genetics Science IVF Medical research UK news Fertility problems Pregnancy Family Parents and parenting Source Type: news
This health care entrepreneur is reinventing fertility treatment
This nursing services provider offers fertility treatments at home. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - December 6, 2023 Category: Biotechnology Authors: Brooke Strickland Source Type: news
Higher Mobile Phone Use Tied to Lower Sperm Counts
TUESDAY, Dec. 5, 2023 -- Higher mobile phone use is associated with lower sperm concentration and sperm count in young men, according to a study published in the December issue of Fertility and Sterility.
Rita Rahban, Ph.D., from the Swiss... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - December 5, 2023 Category: Pharmaceuticals Source Type: news
Trial shows more than 90% of women trying for baby lack essential nutrients
Most of those tested lack nutrients crucial for healthy foetal development as found in abundance in meat and dairy productsMore than 90% of women who are trying for a baby may have marginal or low levels of vitamins that are essential for a healthy pregnancy, according to researchers, who say the problem is likely to worsen as vegetarian diets become more popular.Tests on more than 1,700 women in the UK, New Zealand and Singapore who planned to conceive revealed that most were lacking nutrients found in abundance in meat and dairy products, many of which are crucial for healthy foetal development.Continue reading... (Sourc...
Source: Guardian Unlimited Science - December 5, 2023 Category: Science Authors: Ian Sample Science editor Tags: Science Health Pregnancy Nutrition Fertility problems UK news Society Source Type: news
Roche announces positive Phase III results for inavolisib combination in people with advanced hormone receptor-positive, HER2-negative breast cancer with a PIK3CA mutation
Phase III (INAVO120) results show that inavolisib in combination with palbociclib and fulvestrant significantly improved progression-free survival in the first-line settingPIK3CA mutations, found in approximately 40% of HR-positive breast cancers, are linked to tumour growth, disease progression, and treatment resistance1,2Data will be shared with health authorities and presented at an upcoming medical meetingBasel, 5 December 2023 - Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today positive results from the Phase III INAVO120 study of the investigational therapy, inavolisib, in combination with palbociclib (Ibrance ®) a...
Source: Roche Media News - December 5, 2023 Category: Pharmaceuticals Source Type: news
Roche announces positive Phase III results for inavolisib combination in people with advanced hormone receptor-positive, HER2-negative breast cancer with a PIK3CA mutation
Phase III (INAVO120) results show that inavolisib in combination with palbociclib and fulvestrant significantly improved progression-free survival in the first-line settingPIK3CA mutations, found in approximately 40% of HR-positive breast cancers, are linked to tumour growth, disease progression, and treatment resistance1,2Data will be shared with health authorities and presented at an upcoming medical meetingBasel, 5 December 2023 - Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today positive results from the Phase III INAVO120 study of the investigational therapy, inavolisib, in combination with palbociclib (Ibrance ®) a...
Source: Roche Investor Update - December 5, 2023 Category: Pharmaceuticals Source Type: news
Why are we still struggling to get contraception right? – podcast
As the pill becomes available over the counter and free of charge in England, Madeleine Finlay talks to science correspondent Nicola Davis about the problems women in the UK face in getting access to appropriate contraception, and how unwanted side-effects and lack of support have led to a rise in the popularity of fertility awareness-based methods. She also hears from Katie about her own journey trying to find the right contraception for her bodyContinue reading... (Source: Guardian Unlimited Science)
Source: Guardian Unlimited Science - December 5, 2023 Category: Science Authors: Presented and produced by Madeleine Finlay, with Nicola Davis, additional production support by Estelle Uba, sound design by Joel Cox, the executive producer is Ellie Bury Tags: Science Contraception and family planning Women's health England UK news Society Source Type: news
What Are Some Risks For Offspring of Assisted Reproductive Technologies?
Discussion
“ART [assisted reproductive technologies] includes all fertility treatments in which either eggs or embryos are handled. The main type of ART is in vitro fertilization (IVF). IVF involves extracting a woman’s eggs, fertilizing the eggs in the laboratory, and then transferring the resulting embryos into the woman’s uterus through the cervix.” In Europe 2-6% of all births are due to some type of ART and ART occurs in 2% of US births. In 2021 in the US, there were 91,906 live births and 97,128 live born infants due to ART. ART is an enabling medical treatment for subfertile or infertile pati...
Source: PediatricEducation.org - December 4, 2023 Category: Pediatrics Authors: Pediatric Education Tags: Uncategorized Source Type: news
